Federal bill targets endometriosis with research funds and care access study

What does this do?

HR 6682 directs the NIH to fund research on endometriosis treatments and a possible cure, authorizing up to $50 million per year from 2026 to 2030. The bill also requires a government study on why patients struggle to access care, an online information resource, public education campaigns, and a National Academies review of whether race, geography, or income affects health outcomes. A report on treatment barriers must be delivered to Congress within two years.

Who does it affect?

The bill primarily affects people living with endometriosis, their doctors, and insurance companies. State health programs, including Medicaid and the Children's Health Insurance Program, are also involved in the required data review.

Why does it matter?

The bill responds to documented gaps in endometriosis care, including transportation problems, doctor shortages, insurance coverage gaps, and out-of-pocket costs. Requiring data analysis and congressional reporting creates a formal record of barriers that could inform future policy, particularly for minority and underserved communities.

What does it cost, and who pays?

• Up to $50M per year for NIH research
• Five-year window: 2026 to 2030
• Funded through federal authorization

Where does it stand?